GuidanceMedical PhysicistMammography FacilityRadiologistMQSA InspectorCompliance Officer

Quality Mammography Standards: Final Rule Amending 21 CFR Part 900 (FR Doc. 99–9222)

64 FR 18331 · Docket No. 98N-0728 · Effective April 28, 1999

Last Reviewed: August 21, 2026

Publisher
U.S. Food and Drug Administration / Federal Register
Author
William K. Hubbard, Acting Deputy Commissioner for Policy, FDA
Edition
Final Rule — 64 FR 18331, 1999
Pages
3 pages
Added to library
Added August 21, 2026
Loading document…

Overview

This Federal Register final rule (Vol. 64, No. 71, April 14, 1999) amends two sections of the MQSA quality standards regulation (21 CFR Part 900) to resolve a design conflict discovered after the comprehensive MQSA final rule was published October 28, 1997 (62 FR 55852). The 1997 rule required that the x-ray field 'extend to or beyond the edges of the image receptor,' a provision that conflicted with existing EPRC performance standards requiring manufacturers to limit collimation so the x-ray field does not extend beyond the nonchest wall edges. Several manufacturers had already designed systems to meet the EPRC standard, meaning those systems would have been non-compliant with the MQSA regulation as written. This 1999 amendment (1) makes it permissible (but no longer mandatory) for the x-ray field to extend to nonchest wall edges, (2) applies the 2% of SID extension limit uniformly to all edges of the image receptor (correcting an omission that applied it only to the chest wall side), and (3) consolidates all alignment requirements into §900.12(e)(5)(vii)(A), removing alignment language from §900.12(b)(5) while preserving the light field illumination requirement.

Key Contents

-Regulatory action: Final rule amending 21 CFR Part 900 | Docket No. 98N-0728 | FR Doc. 99–9222

-Published: Federal Register Vol. 64, No. 71 (April 14, 1999), pages 18331–18333

-Effective date: April 28, 1999 (same effective date as the main MQSA final rule, 62 FR 55852)

-Signed by: William K. Hubbard, Acting Deputy Commissioner for Policy, April 7, 1999

-Sections amended:

• §900.12(b)(5) Light fields: retained illumination standard (160 lux at 100 cm or max SID); alignment language removed and consolidated below

• §900.12(e)(5)(vii)(A) Beam-limiting devices: revised to require (a) chest wall edge of x-ray field reaches chest wall edge of image receptor AND (b) x-ray field does not extend beyond ANY edge of image receptor by more than 2% of SID

-Two problems corrected:

1. Collimation conflict: The 1997 rule required the x-ray field to extend to or beyond image receptor edges, but EPRC standards required manufacturers to limit collimation below those edges. Amended rule makes reaching the nonchest wall edges permissible, not mandatory.

2. SID limit omission: The 2% of SID extension limit had been applied only to the chest wall side. Corrected to apply to all edges of the image receptor.

-Background: MQSA enacted October 27, 1992 (Pub. L. 102–539); interim rules 58 FR 67558 and 58 FR 67565 (December 21, 1993); comprehensive final rule 62 FR 55852 (October 28, 1997)

-Proposed amendment published November 5, 1998 (63 FR 59750); two public comments received, both supportive

-Economic impact: No significant negative impact on small entities; no Unfunded Mandates Reform Act threshold triggered

-No Paperwork Reduction Act burden: no new information collections

-Contact: Roger L. Burkhart, CDRH (HFZ-240), FDA, 1350 Piccard Dr., Rockville, MD 20850 | 301–594–3332

How This Applies to Your Practice

This amendment established and codified the operative 21 CFR § 900.12(e)(5)(vii)(A) language that MQSA inspectors use today when evaluating beam-limiting device and collimation compliance. The corrected two-part requirement, (a) the x-ray field must reach the chest wall edge of the image receptor AND (b) the x-ray field must not extend beyond any edge of the image receptor by more than 2% of the SID, is a standard quality control test item in the medical physicist's annual survey and the technologist's routine QC checklist. When facilities or physicists reference the operative text of 21 CFR Part 900 on beam-limiting device collimation, they are relying on language as amended April 28, 1999, not the original 1997 final rule text at 62 FR 55852. This distinction matters if a facility contests an inspection finding related to x-ray field alignment: the applicable citation is § 900.12(e)(5)(vii)(A) as amended by this rule, and the pre-amendment language requiring the x-ray field to 'extend to or beyond the edges of the image receptor' was explicitly superseded. QC manuals, physicist annual survey reports, and compliance documentation that cite collimation standards should confirm they reflect the post-amendment requirement.

Practitioner Implications

Medical physicists conducting MQSA annual surveys must apply the two-part collimation standard from § 900.12(e)(5)(vii)(A) as amended: (1) the x-ray field must reach the chest wall edge of the image receptor, and (2) the x-ray field must not extend beyond any edge by more than 2% of the SID. The 2% limit applies to all four edges of the image receptor, not only the chest wall side; this was the specific omission corrected by this 1999 rule. Technologists performing routine QC should confirm that any collimation-related test in the facility's QC manual reflects both conditions. If a QC manual references only the chest wall alignment requirement without the all-edges 2%-of-SID limit, it predates this amendment and needs updating. Facilities that have received past inspection findings related to x-ray field alignment should verify that the inspector cited the post-April 28, 1999 text. The pre-amendment version of § 900.12(e)(5)(vii)(A), which required the field to 'extend to or beyond the edges of the image receptor', was superseded by this rule and should not appear in current compliance documentation, QC manuals, or physicist survey reports.

Disclaimer

The content, articles, calculators, tools, estimates, projections, derived data, reports, and other materials provided by Mammologix, LLC, powered by I/O Trak, Inc. (“Mammologix”) are provided for informational and educational purposes only.

The information and outputs provided by Mammologix are not intended to serve as, and should not be relied upon as, medical advice, diagnosis, treatment, clinical guidance, financial advice, investment advice, tax advice, legal advice, accounting advice, or any other professional advice.

Information provided by Mammologix may relate to breast health, mammography, imaging, screening, diagnostics, clinical outcomes, healthcare topics, financial calculations, estimates, projections, or other decision-support information. However, such information should not be used to make personal medical, clinical, financial, investment, business, insurance, legal, or other important decisions without consulting an appropriate qualified professional.

Always seek the advice of a licensed physician, radiologist, healthcare provider, financial advisor, accountant, attorney, or other qualified professional with any questions you may have about a medical condition, screening recommendation, imaging result, treatment option, financial matter, or other professional decision. Never disregard professional medical, financial, legal, or other advice, or delay seeking such advice, because of something you have read, calculated, or received through Mammologix.

Any calculators, formulas, estimates, projections, derived medical outcome data, financial calculations, or other tool-generated outputs are provided as estimates only. Results may be affected by user-entered information, assumptions, formula limitations, incomplete or inaccurate data, rounding, software errors, third-party data, changing medical guidelines, changing financial conditions, changes in law or regulation, or other factors. Mammologix does not represent, warrant, or guarantee that any calculation, output, article, estimate, projection, or derived data is accurate, complete, current, reliable, suitable, or appropriate for any particular purpose.

For medical or health-related content and calculators, Mammologix does not provide medical advice, diagnosis, treatment recommendations, diagnostic interpretation, or patient-specific clinical decision-making. Mammologix content and tools are not a substitute for an in-person evaluation, professional medical consultation, diagnostic interpretation, or individualized care from a licensed healthcare provider. In the event of a medical emergency, contact emergency services or a qualified healthcare provider immediately.

For financial, business, tax, investment, or accounting-related calculators or content, Mammologix does not provide financial, investment, tax, legal, accounting, or business advice. Any outputs are estimates only, and actual results may vary materially based on personal circumstances, market conditions, taxes, fees, interest rates, inflation, risk tolerance, regulatory changes, and other factors.

Use of Mammologix content, articles, calculators, tools, and outputs is at your own risk. You are solely responsible for reviewing, verifying, and interpreting any information or results provided and for obtaining appropriate professional advice before relying on or acting upon such information.

Mammologix assumes no liability for any injury, loss, claim, damage, or expense arising from or related to the use of, reliance on, or inability to use any Mammologix content, article, calculator, tool, estimate, projection, derived data, report, or website material. To the fullest extent permitted by law, Mammologix, its owners, officers, employees, contractors, affiliates, licensors, service providers, and agents disclaim all liability for any direct, indirect, incidental, consequential, special, exemplary, punitive, financial, medical, clinical, business, or other damages arising out of or relating to the use of Mammologix materials or outputs.

The information provided by Mammologix does not establish a doctor-patient, provider-patient, radiologist-patient, financial advisor-client, attorney-client, accountant-client, fiduciary, or other professional relationship.

AI Content Disclosure

Some Mammologix content, calculations, summaries, tools, or outputs may be created, edited, generated, or assisted by artificial intelligence tools or automated systems. While Mammologix may review content for accuracy and relevance, AI-assisted or automated materials may contain errors, omissions, inaccuracies, outdated information, or outputs that are incomplete or inappropriate for a particular user, patient, circumstance, or purpose.

Users should independently verify all AI-assisted content, calculator outputs, and automated results with appropriate qualified professionals before relying on them.

Didn't find what you were looking for?

Our team has supported breast imaging centers since 1995. If it's not here, we probably know the answer.

Ask a Question →